Exosomes derived from these CAR-T cells carrying PRF1 and GZMB exhibited high cytotoxicity against TNBC cell lines and reduced tumor volumes in xenograft models, highlighting the potential of exosome-mediated therapy in TNBC [237]. The gene discussed is PRF1; the disease is neoplasm.